Nicola De Franceschi (Laboratory of Membrane Machines) is another IMol Group Leader awarded the SONATA BIS 12 for his project “Reconstitution of viral double-membrane vesicles: towards in vitro organellogenesis”. As Nicola explains: – The project regards the reconstitution of viral double-membrane vesicles. It aims at studying the mechanisms of membrane rearrangements induced in cells upon […]
Our next project awarded the SONATA BIS 12 grant is “Coordination of the spliceosome expression-to-function during embryonic development” by Dr. Maciej Cieśla (Laboratory of Stem Cell RNA Metabolism). As Maciej describes it: – During development, embryonic stem cells, capable of formation of entire organism are formed. With this project, we will understand how differentiation of […]
Zaktualizowano: 21 mar 2023 We’ve already informed that four of our Group Leaders have been awarded the SONATA BIS 12 grant. In the next few posts, we will take a closer look at their winning projects. Dr. Abdelhalim Azzi (Laboratory of Lipids and Chronobiology) about his his project “Circadian signaling functions of the phosphoinositide phosphatase SHIP2”: […]
Dr. Paweł Mikulski, who will join IMol as a Group Leader in mid-2023, is among the laureates of the NAWA Polish Returns programme. Under this programme Paweł will receive funding for the realization of his project ‘The role of genome architecture and related chromatin modifications in innate immune transcriptional memory of antigen presentation genes’. Congratulations!
We are glad to invite you to the next edition of IMol Science Club on March 22nd. This time we will be joined by Marina Rodnina of Max Planck Institute for Multidisciplinary Sciences. In her talk Prof. Rodnina will summarize the recent advances in understanding the mechanisms of three types of recoding events: stop-codon readthrough, […]
Today we are celebrating Rare Disease Day. There are over 7,000 rare diseases which impact over 300 million people all around the world. Among these conditions are mitochondrial diseases – early degenerations which occur inside the cell. To overcome them is a challenge for scientists and doctors alike. At IMol, we aim to combat the […]